文献速递慢病管理常见症状与未分化疾病预防保健、筛查与疫苗

既存疾病对食管胃癌诊断分期的影响:基于电子病历的原发性保健队列研究

Quantifying the impact of pre-existing conditions on the stage of oesophagogastric cancer at diagnosis: a primary care cohort study using electronic medical records.
PubMed 文献 · Fam Pract · 2021-01-01

该回顾性队列研究利用CPRD数据与英国癌症登记链接,纳入2010—2015年新诊断食管胃癌、年龄≥40岁的1749例患者,分析既存疾病与诊断时分期的关联。结果显示,多病共存与分期相关(OR 0.63,95%CI 0.47-0.85,P=0.002),且与性别存在交互(OR 1.76,95%CI 1.08-2.86,P=0.024);男性多病共存者晚期概率较低(70% vs 79%),女性则相近。提供替代诊断解释与分期无关(OR 1.18,95%CI 0.87-1.60,P=0.278)。

要点

  • 男性多病共存者晚期食管胃癌概率较低(70% vs 79%),女性相近。
  • 多病共存与分期相关(OR 0.63,95%CI 0.47-0.85),并与性别有交互。
  • 存在可解释癌症症状的替代诊断与分期无关(OR 1.18,95%CI 0.87-1.60)。

核心结论

  • 在男性中,多病共存与食管胃癌晚期概率降低相关,降至女性总体水平。
  • 既存疾病使癌症诊断复杂化:若解释症状或占据就诊时间可能延迟诊断,若增加医患接触可能加快诊断。

研究设计与样本

  • 回顾性队列研究,使用CPRD数据链接英国癌症登记。
  • 纳入2010年1月1日至2015年12月31日新诊断食管胃癌、年龄≥40岁且诊断前一年内就诊原发性保健者。
  • 排除缺失分期者695例后,1749例纳入分析。
  • logistic回归分析分期与多病共存(≥2种疾病,参照:无多病共存)及存在「诊断替代解释」的关联,控制年龄、性别、剥夺指数和癌症部位。

主要发现

  • 1749例中1265例(72.3%)为晚期。
  • 多病共存与分期相关:OR 0.63,95%CI 0.47-0.85,P=0.002。
  • 多病共存与性别交互项:OR 1.76,95%CI 1.08-2.86,P=0.024,有中等证据。
  • 替代解释与分期无关联:OR 1.18,95%CI 0.87-1.60,P=0.278。
  • 女性多病共存者晚期概率71%(95%CI 66-75%),无多病共存者69%(95%CI 62-76%);男性多病共存者70%(95%CI 67-74%),无多病共存者79%(95%CI 75-83%)。

临床怎么用

  • 全科医生应意识到既存疾病可能通过提供症状替代解释或竞争就诊注意力而延迟癌症诊断。
  • 对多病共存男性患者,既存疾病增加医患接触可能有助于更早诊断,但仍需警惕癌症症状。

局限性

  • 28%的参与者因缺失分期被排除,可能引入选择偏倚。
  • 研究为回顾性观察设计,无法确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pre-existing conditions interfere with cancer diagnosis by offering diagnostic alternatives, competing for clinical attention or through patient surveillance. OBJECTIVE: To investigate associations between oesophagogastric cancer stage and pre-existing conditions. METHODS: Retrospective cohort study using Clinical Practice Research Datalink (CPRD) data, with English cancer registry linkage. Participants aged ≥40 years had consulted primary care in the year before their incident diagnosis of oesophagogastric cancer in 01/01/2010-31/12/2015. CPRD records pre-diagnosis were searched for codes denoting clinical features of oesophagogastric cancer and for pre-existing conditions, including those providing plausible diagnostic alternatives for those features. Logistic regression analysed associations between stage and multimorbidity (≥2 conditions; reference category: no multimorbidity) and having 'diagnostic alternative(s)', controlling for age, sex, deprivation and cancer site. RESULTS: Of 2444 participants provided, 695 (28%) were excluded for missing stage, leaving 1749 for analysis (1265/1749, 72.3% had advanced-stage disease). Multimorbidity was associated with stage [odds ratio 0.63, 95% confidence interval (CI) 0.47-0.85, P = 0.002], with moderate evidence of an interaction term with sex (1.76, 1.08-2.86, P = 0.024). There was no association between alternative explanations and stage (odds ratio 1.18, 95% CI 0.87-1.60, P = 0.278). CONCLUSIONS: In men, multimorbidity is associated with a reduced chance of advanced-stage oesophagogastric cancer, to levels seen collectively for women. Diagnosing cancer is complicated by existing medical conditions. Diagnosis may be delayed if conditions explain cancer symptoms, or dominate appointments. Diagnosis may be quicker if conditions increase doctor–patient contact. We studied the association between existing illness and stage (early or advanced) of diagnosis with cancer of the stomach or gullet. We studied the primary-care records of patients aged ≥40 years, diagnosed in 01/01/2010–31/12/2015, and got stage from English cancer registry data. We searched the primary-care records for cancer symptoms (e.g. difficulty swallowing), and for 27 conditions that were common or explained cancer symptoms (e.g. difficulty swallowing following a stroke). We analysed cancer stage, looking at age, sex, multimorbidity (two or more conditions) and explanations for symptoms. We studied 1749 patients, of whom 1265 (72.3%) had advanced-stage cancer. The chance of advanced stage was similar in women with (71%, 95% CI 66–75%) or without (69%, 62–76%) multimorbidity. It was lower for men with (70%, 67–74%) than without (79%, 75–83%) multimorbidity. Stage of cancer was not affected by having explanations for cancer symptoms. In summary, for men, multimorbidity is associated with a reduced chance of advanced-stage cancer of the stomach or gullet to levels seen collectively for women.

来源:Fam Pract,查看原文。版权归原作者所有。

引用

  1. Quiroga M, Shephard EA, Mounce LTA, et al. Quantifying the impact of pre-existing conditions on the stage of oesophagogastric cancer at diagnosis: a primary care cohort study using electronic medical records. Fam Pract. 2021. PMID: 33346832. doi:10.1093/fampra/cmaa132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。